Exalys Therapeutics
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $15M
Investors
- 2
About Exalys Therapeutics
Exalys Therapeutics, Inc.Exalys Therapeutics, Inc. specializes in innovative solutions that improve operational efficiencies through advanced data analytics. The company is headquartered in San Diego, US. Rick Orr serves as the CEO.Exalys Therapeutics, Inc. specializes in offering innovative technology solutions designed to address various industry challenges. The core product offerings include advanced analytics platforms and decision-support tools aimed at enhancing operational efficiencies and enabling data-driven decision-making. These products are tailored for diverse sectors such as finance, healthcare, and logistics, providing end users with actionable insights to optimize their processes and drive strategic growth.The revenue model for Exalys Therapeutics, Inc. is structured around subscription-based services, enabling clients to access its suite of products while providing a steady flow of income to the company. Clients engage with the firm's analytics tools through tiered pricing plans that cater to various usage levels, allowing businesses to select the package that best fits their operational needs. Transactions are typically structured as annual or multi-year agreements, fostering long-term partnerships with clients. Flagship products offered by the company include its proprietary analytics platform, which delivers comprehensive insights into key performance indicators. This strategic approach ensures that Exalys Therapeutics, Inc.Exalys Therapeutics, Inc. The company targets expansion into European markets by the end of 2023, aiming to capitalize on increasing demand for advanced data solutions.
Who invested in Exalys Therapeutics
2 investors across 1 round
See all investors in Exalys Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 16, 2020
Amount
$15M
Investors
Questions about Exalys Therapeutics
Who invested in Exalys Therapeutics?
Exalys Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exalys Therapeutics raised?
Exalys Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Exalys Therapeutics last raise money?
Exalys Therapeutics's most recent round on record is a Series A, in Jul 2020.
What does Exalys Therapeutics do?
Exalys Therapeutics is a biotechnology company.
Where is Exalys Therapeutics headquartered?
Exalys Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Exalys Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Exalys Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Exalys Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.